journal cover

Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris

Emerging Infectious Diseases

Jan 19, 2017

Leighann SherryRiina Rautemaa-Richardson

Abstract

The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare-associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive to the disinfectant chlorhexidin...read more

Mentioned in this Paper

Pathogenicity
Pathogenic Organism
Antibiotics, Antifungal
Yeasts
Chlorhexidine
Antheraea
P-Glycoproteins
Candidiasis
Virulence Factors
Cronobacter phage ES2
38
51
4
150
1
Paper Details
References
  • References
  • Citations37
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations37
1234

Feeds With Similar Papers

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Multi-drug Resistance

Multi-drug resistance or multiresistance is antimicrobial resistance shown by a species of microorganism to multiple antimicrobial drugs. Discover the latest research on multi-drug resistance here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Emerging Infectious Diseases (ASM)

Emerging Infectious Diseases are defined as those whose incidence in humans has increased in the past two decades or threaten to increase in the near future. Discover the latest research on Emerging Infectious Diseases.

Multi-drug Resistance (ASM)

Multi-drug resistance or multiresistance is antimicrobial resistance shown by a species of microorganism to multiple antimicrobial drugs. Discover the latest research on multi-drug resistance here.

Emerging Infectious Diseases

Emerging Infectious Diseases are defined as those whose incidence in humans has increased in the past two decades or threaten to increase in the near future. Discover the latest research on Emerging Infectious Diseases.

Virulence Factors

Virulence factors are molecules that are produced by organisms including bacteria, viruses, and fungi. They assist the organism in colonization, dissemination, and enhance the ability to survive in harsh environments and evade the host immune system. Discover the latest research on virulence factors here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Ebola Virus

Ebola Virus causes ebola virus disease, and is one of the deadliest pathogens known to man, with a mortality rate between 25-90% depending on the species and outbreak of ebola. Discover the latest research on Ebola Virus.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Related Papers

The Journal of Hospital Infection

Multidrug-resistant Candida auris: 'new kid on the block' in hospital-associated infections?

The Journal of Hospital InfectionSeptember 17, 2016
Anuradha ChowdharyJacques F Meis
Methods in Enzymology

Candida biofilms and their susceptibility to antifungal agents

Methods in EnzymologyNovember 5, 1999
G S Baillie, L J Douglas
© 2020 Meta ULC. All rights reserved

Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris

Emerging Infectious Diseases

Jan 19, 2017

Leighann SherryRiina Rautemaa-Richardson

PMID: 28098553

DOI: 10.3201/eid2302.161320

Abstract

The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare-associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive to the disinfectant chlorhexidin...read more

Mentioned in this Paper

Pathogenicity
Pathogenic Organism
Antibiotics, Antifungal
Yeasts
Chlorhexidine
Antheraea
P-Glycoproteins
Candidiasis
Virulence Factors
Cronobacter phage ES2
38
51
4
150
1

Feeds With Similar Papers

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

The Journal of Hospital Infection

Multidrug-resistant Candida auris: 'new kid on the block' in hospital-associated infections?

The Journal of Hospital InfectionSeptember 17, 2016
Anuradha ChowdharyJacques F Meis
Methods in Enzymology

Candida biofilms and their susceptibility to antifungal agents

Methods in EnzymologyNovember 5, 1999
G S Baillie, L J Douglas
Paper Details
References
  • References
  • Citations37
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations37
1234

Download from

Publisher
PubMed
/papers/biofilm-forming-capability-of-highly-virulent/28098553